{"name":"Alnylam Pharmaceuticals","permalink":"alnylam-pharmaceuticals-2","crunchbase_url":"http://www.crunchbase.com/company/alnylam-pharmaceuticals-2","homepage_url":"http://www.alnylam.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"","phone_number":"617-551-8200","description":"","created_at":"Tue Mar 29 02:51:50 UTC 2011","updated_at":"Wed Aug 29 03:42:22 UTC 2012","overview":"<p>Alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as RNA interference, or RNAi. With RNAi technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today&#8217;s medicines.</p>","image":{"available_sizes":[[[150,40],"assets/images/resized/0012/8181/128181v1-max-150x150.png"],[[173,47],"assets/images/resized/0012/8181/128181v1-max-250x250.png"],[[173,47],"assets/images/resized/0012/8181/128181v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"CEO","person":{"first_name":"John","last_name":"Maraganore","permalink":"john-maraganore","image":null}},{"is_past":false,"title":"President and COO","person":{"first_name":"Barry","last_name":"Greene","permalink":"barry-greene-2","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$10M","funding_rounds":[{"round_code":"unattributed","source_url":"http://www.masshightech.com/stories/2011/03/28/daily4-Alnylam-lands-10M-pay-from-Takeda.html","source_description":"Alnylam lands $10M pay from Takeda","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":3,"funded_day":28,"investments":[{"company":{"name":"Takeda Pharmaceutical","permalink":"takeda-pharmaceutical","image":{"available_sizes":[[[82,32],"assets/images/resized/0005/9044/59044v2-max-150x150.png"],[[82,32],"assets/images/resized/0005/9044/59044v2-max-250x250.png"],[[82,32],"assets/images/resized/0005/9044/59044v2-max-450x450.png"]],"attribution":null}},"financial_org":null,"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"300 Third Street","address2":"3rd Floor","zip_code":"02142","city":"Cambridge","state_code":"MA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[{"description":"promoted Akshay K. Vaishnaw, M.D., Ph.D., to the new position of chief medical officer","stoned_year":2011,"stoned_month":6,"stoned_day":13,"source_url":"http://www.masshightech.com/stories/2011/06/13/daily8-Vaishnaw-named-medical-officer-at-Alnylam.html","source_text":null,"source_description":"Vaishnaw named medical officer at Alnylam","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Alnylam Pharmaceuticals","permalink":"alnylam-pharmaceuticals-2"}},{"description":"Alnylam gets $3.2M payment from Glaxo","stoned_year":2012,"stoned_month":7,"stoned_day":30,"source_url":"http://www.masshightech.com/stories/2012/07/30/daily7-Alnylam-gets-32M-payment-from-Glaxo.html","source_text":"","source_description":"Alnylam gets $3.2M payment from Glaxo","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Alnylam Pharmaceuticals","permalink":"alnylam-pharmaceuticals-2"}},{"description":"Alnylam reaps $29M harvest in new ag bio deal with Monsanto","stoned_year":2012,"stoned_month":8,"stoned_day":28,"source_url":"http://www.fiercebiotech.com/story/alnylam-reaps-29m-harvest-new-ag-bio-deal-monsanto/2012-08-28?utm_source=rss&utm_medium=rss","source_text":"","source_description":"Alnylam reaps $29M harvest in new ag bio deal with Monsanto","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Alnylam Pharmaceuticals","permalink":"alnylam-pharmaceuticals-2"}}],"ipo":{"valuation_amount":null,"valuation_currency_code":"USD","pub_year":null,"pub_month":null,"pub_day":null,"stock_symbol":"NASDAQ:ALNY"},"video_embeds":[],"screenshots":[],"external_links":[]}